Hallman Mark A, Zhuang Shougang, Schnellmann Rick G
Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St., P.O.B. 250140, Charleston, SC 29425, USA.
J Pharmacol Exp Ther. 2008 May;325(2):520-8. doi: 10.1124/jpet.107.134031. Epub 2008 Feb 12.
Repair of injured renal epithelium is thought to be mediated by surviving renal proximal tubular cells (RPTC) that must dedifferentiate to allow the proliferation and migration necessary for epithelial regeneration. RPTC then redifferentiate to restore tubular structure and function. Current models suggest that epidermal growth factor receptor (EGFR) activation is required for dedifferentiation characterized by enhanced vimentin expression, decreased N-cadherin expression, spindle morphology, and loss of apical-basal polarity after injury. Because an in vitro model of RPTC redifferentiation has not been reported, and the mechanism(s) of redifferentiation has not been determined, we used rabbit RPTC in primary cultures to address these issues. H2O2 induced the dedifferentiated phenotype that persisted >48 h; redifferentiation occurred spontaneously in the absence of exogenous growth factors after 72 to 120 h. Phosphorylation of two tyrosine residues of EGFR increased 12 to 24 h, peaked at 24 h, and declined to basal levels by 48 h after injury. EGFR inhibition during dedifferentiation restored epithelial morphology and apical-basal polarity, and it decreased vimentin expression to control levels 24 h later. In contrast, exogenous epidermal growth factor addition increased vimentin expression and potentiated spindle morphology. p38 mitogen-activated protein kinase (MAPK) and transforming growth factor (TGF)-beta receptor inhibitors did not affect redifferentiation after H2O2 injury. Similar results were observed in a mechanical injury model. These experiments represent a new model for the investigation of RPTC redifferentiation after acute injury and identify a key regulator of redifferentiation: EGFR, independent of p38 MAPK and the TGF-beta receptor.
受损肾上皮的修复被认为是由存活的肾近端小管细胞(RPTC)介导的,这些细胞必须去分化,以实现上皮再生所需的增殖和迁移。然后,RPTC再分化以恢复肾小管结构和功能。目前的模型表明,表皮生长因子受体(EGFR)激活是去分化所必需的,其特征是损伤后波形蛋白表达增强、N-钙黏蛋白表达降低、纺锤体形态以及顶端-基底极性丧失。由于尚未报道RPTC再分化的体外模型,且再分化的机制尚未确定,我们使用原代培养的兔RPTC来解决这些问题。过氧化氢诱导去分化表型持续超过48小时;在没有外源性生长因子的情况下,72至120小时后自发发生再分化。损伤后12至24小时,EGFR的两个酪氨酸残基磷酸化增加,在24小时达到峰值,并在48小时降至基础水平。去分化过程中抑制EGFR可恢复上皮形态和顶端-基底极性,并在24小时后将波形蛋白表达降低至对照水平。相反,添加外源性表皮生长因子会增加波形蛋白表达并增强纺锤体形态。p38丝裂原活化蛋白激酶(MAPK)和转化生长因子(TGF)-β受体抑制剂对过氧化氢损伤后的再分化没有影响。在机械损伤模型中也观察到了类似的结果。这些实验代表了一种研究急性损伤后RPTC再分化的新模型,并确定了再分化的关键调节因子:EGFR,独立于p38 MAPK和TGF-β受体。